Global patterns and trends in colorectal cancer incidence and mortality.Gut. 2017; 66: 683-691
- Siegel R.L.
- Miller K.D.
- Jemal A.
Cancer statistics, 2016.CA Cancer J Clin. 2016; 66: 7-30
Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology.J Natl Compr Cancer Netw. 2021; 19: 329-359
Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database.J Clin Oncol. 2016; 34: 843
Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2013; 24 ()
Treatment of colorectal cancer in the elderly.World J Gastrointest Oncol. 2015; 7: 204
Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.Med Oncol. 2017; 34: 1-6
- Nitsche U.
- Stöss C.
- Friess H.
Effect of adjuvant chemotherapy on elderly colorectal cancer patients: lack of evidence.Gastroint Tumors. 2017; 4: 11-19
Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.PLoS One. 2020; 15e0239819
Early reduction in ctDNA predicts survival in patients with lung and bladder Cancer treated with Durvalumab.Clin Cancer Res. 2018; 24: 6212-6222
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.Nat Mater. 2017; 16: 1155-1161
Next-generation sequencing in liquid biopsy: cancer screening and early detection.Hum Genomics. 2019; 13: 1-10
Liquid biopsy detects relapse five months earlier than regular clinical follow-up and guides targeted treatment in breast cancer.Case Rep Oncol Med. 2019; https://doi.org/10.1155/2019/6545298
Analysis of plasma cell-free DNA by Ultradeep sequencing in patients with stages I to III colorectal Cancer.JAMA Oncol. 2019; 5: 1124-1131
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.Ann Oncol. 2019; 30: 1804-1812
Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer.JAMA Oncol. 2019; 5: 1710-1717
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?.J Clin Oncol. 2004; 22: 1797-1806
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.J Clin Oncol. 2009; 27: 3109-3116
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.N Engl J Med. 2001; 345: 1091-1097
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.J Clin Oncol. 2012; 30: 2624
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.J Clin Oncol. 2007; 25: 2198-2204
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.J Clin Oncol. 2013; 31: 2600
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.Ann Oncol. 2015; 26: 715-724
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.Ann Oncol. 2015; 26: 463-476
Challenges in the management of older patients with colon cancer.J Natl Compr Cancer Netw. 2012; 10 (): 213-224
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.J Clin Oncol. 2014; 32: 2595-2603
Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score.Cancer. 2012; 118: 3377-3386
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.J Clin Oncol. 2011; 29: 3457
Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE.Aging (Albany NY). 2020; 12: 4230-4246
Performance of four frailty classifications in older patients with Cancer: prospective elderly Cancer patients cohort study.J Clin Oncol. 2017; 35: 766-777
Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of two widely used prognostic calculators.in: Seminars in oncology. Elsevier,
Validity of adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.J Geriatr Oncol. 2016; 7: 422-429
A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer.Crit Rev Oncol Hematol. 2021; 168103528
Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.PLoS One. 2017; 12e0174308
Circulating mutant DNA to assess tumor dynamics.Nat Med. 2008; 14: 985-990
Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer.Sci Rep. 2019; 9: 17358
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.Sci Transl Med. 2016; 8: 346ra92
Circulating tumor DNA analysis guiding adjuvant therapy in stage II Colon Cancer.N Engl J Med. 2022; 386: 2261-2272https://doi.org/10.1056/NEJMoa2200075
Adjuvant chemotherapy in patients with colorectal cancer. Is there a role in the older adult?.Eur J Surg Oncol. 2020; 46: 363-368
The future of ctDNA-defined minimal residual disease: personalizing adjuvant therapy in CRC.Clin Colorectal Cancer. 2022; 21: 85-89https://doi.org/10.1016/j.clcc.2022.03.004